Siegfried Holding AG
Global CDMO providing development and manufacturing of APIs and finished drugs for the pharma industry.
SFZN | SW
Overview
Corporate Details
- ISIN(s):
- CH0014284498 (+3 more)
- LEI:
- 506700J9QD6IF3937W06
- Country:
- Switzerland
- Address:
- Untere Brühlstrasse 4, 4800 Zofingen
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Siegfried Holding AG is a global Contract Development and Manufacturing Organization (CDMO) that partners with the pharmaceutical industry. With over 150 years of experience, the company operates as an integrated supplier, providing services across the entire value chain for both drug substances and finished drug products. Its core activities include chemical and analytical development, pilot manufacturing, scale-up, and commercial production of active pharmaceutical ingredients (APIs), intermediates, and various finished dosage forms like tablets, capsules, and sterile injectables. Siegfried leverages its global network of R&D and production sites to translate pharmaceutical innovations into industrial-scale manufacturing, producing medications for patients worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-29 06:30 |
Regulatory News Service
DINAMIQS opens cGMP manufacturing facility for viral vectors
|
English | 20.5 KB | ||
| 2025-09-29 02:00 |
Regulatory News Service
DINAMIQS opens cGMP manufacturing facility for viral vectors
|
English | 16.6 KB | ||
| 2025-09-26 06:30 |
Board/Management Information
Change in the Chairmanship of the Board of Directors
|
English | 18.0 KB | ||
| 2025-09-26 02:00 |
Board/Management Information
Change in the Chairmanship of the Board of Directors
|
English | 14.1 KB | ||
| 2025-09-11 02:00 |
Capital/Financing Update
Siegfried successfully places senior bonds of CHF 300 million
|
English | 12.3 KB | ||
| 2025-07-17 06:30 |
Board/Management Information
Change in Siegfried's Executive Committee
|
English | 17.8 KB | ||
| 2025-05-23 06:30 |
Regulatory News Service
Siegfried expands production capacity for ophthalmic drugs in El Masnou
|
English | 18.6 KB | ||
| 2025-05-23 02:00 |
Regulatory News Service
Siegfried expands production capacity for ophthalmic drugs in El Masnou
|
English | 13.7 KB | ||
| 2025-04-10 15:30 |
Post-Annual General Meeting Information
Siegfried shareholders approve all proposals at Annual General Meeting 2025
|
English | 19.4 KB | ||
| 2025-02-18 01:00 |
Earnings Release
Siegfried reports continued profitable growth fueled by strong underlying busin…
|
English | 19.1 KB | ||
| 2024-12-24 06:30 |
Environmental & Social Information
Siegfried once again confirmed in the Dow Jones Sustainability Index Europe
|
English | 15.8 KB | ||
| 2024-12-23 06:30 |
Environmental & Social Information
Siegfried once again confirmed in the Dow Jones Sustainability Index Europe
|
English | 15.8 KB | ||
| 2024-12-23 01:00 |
Environmental & Social Information
Siegfried once again confirmed in the Dow Jones Sustainability Index Europe
|
English | 12.1 KB | ||
| 2024-12-07 06:30 |
Board/Management Information
Changes in Siegfried's senior management team
|
English | 17.7 KB | ||
| 2024-12-06 06:30 |
Board/Management Information
Changes in Siegfried's senior management team
|
English | 17.7 KB |
Automate Your Workflow. Get a real-time feed of all Siegfried Holding AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Siegfried Holding AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-10-31 | N/A | Executive member | Sell | None | 1,695,000.00 CHF |
| 2024-10-31 | N/A | Executive member | Sell | None | 1,584,260.00 CHF |
| 2024-08-28 | N/A | Executive member | Sell | None | 1,086,000.00 CHF |
| 2024-08-28 | N/A | Executive member | Sell | None | 380,100.00 CHF |
| 2024-08-28 | N/A | Executive member | Sell | None | 362,724.00 CHF |
| 2024-06-14 | N/A | Non-Executive member | Sell | None | 368,930.00 CHF |
| 2024-03-06 | N/A | Executive member | Sell | None | 4,587,500.00 CHF |
| 2024-03-06 | N/A | Executive member | Sell | None | 1,376,250.00 CHF |
| 2024-03-06 | N/A | Executive member | Sell | None | 917,500.00 CHF |
| 2024-03-06 | N/A | Executive member | Sell | None | 458,750.00 CHF |
